74131-59-2 Usage
Physical state
Colorless liquid
Explanation
The compound is in a liquid state and has no color, making it transparent.
Explanation
The compound has a pleasant, sweet, and floral scent, which is why it is used in the fragrance industry.
Explanation
Due to its pleasant odor, 1,3-Benzodioxole, 4,7-dimethylis commonly used in perfumes and personal care products. It is also utilized in the synthesis of various pharmaceuticals and other organic compounds.
Explanation
Handling this chemical requires caution, as it can cause irritation to the skin, eyes, and respiratory system if not properly managed.
Explanation
If released into the environment, this compound may have negative effects on aquatic life, making it important to handle and dispose of it responsibly.
Odor
Sweet, floral
Applications
Fragrance ingredient, synthesis of pharmaceuticals and organic compounds
Safety precautions
Irritating to skin, eyes, and respiratory system
Environmental impact
Potentially harmful to aquatic organisms
Check Digit Verification of cas no
The CAS Registry Mumber 74131-59-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,1,3 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 74131-59:
(7*7)+(6*4)+(5*1)+(4*3)+(3*1)+(2*5)+(1*9)=112
112 % 10 = 2
So 74131-59-2 is a valid CAS Registry Number.
74131-59-2Relevant articles and documents
2-IMIDAZOLINYLAMINO HETEROCYCLIC COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS
-
, (2008/06/13)
The subject invention relates to compounds having the structure: STR1 wherein (a) n is an integer from 1 to about 3; (b) X and Y are each independently selected from O, S and CH 2, with at least one of X and Y being O or S;(c) R is unsubstituted, straight or branched chain alkanyl or alkanoxy having from 1 to about 3 non-hydrogen atoms; and(d) R' is selected from hydrogen, methyl, cyano, and halo; pharmaceutical compositions containing such compounds; and the use of such compounds for preventing or treating of disorders modulated by alpha-2 adrenoceptors.